<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02788019</url>
  </required_header>
  <id_info>
    <org_study_id>STU 092015-065</org_study_id>
    <nct_id>NCT02788019</nct_id>
  </id_info>
  <brief_title>Adductor Canal Mid-thigh and Adductor Canal Distal Thigh: Is Cutaneous Sensory Blockade Similar Among Block Techniques?</brief_title>
  <official_title>Adductor Canal Mid-thigh and Adductor Canal Distal Thigh: Is Cutaneous Sensory Blockade Similar Among Block Techniques?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Texas Southwestern Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Texas Southwestern Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized noninferiority interventional study to determine the equivalence of two&#xD;
      adductor canal block (ACB) methods: mid-thigh and distal thigh in patients undergoing medial&#xD;
      foot, medial ankle, or medial leg surgery. Sixty eight patients will be identified during&#xD;
      their orthopedic presurgical clinic visit, anesthesia preoperative clinic visit or Day&#xD;
      Surgery Unit (Zale Lipshy Hospital, Clements University Hospital, and University of Texas&#xD;
      Southwestern Outpatient Surgery Center) for eligibility. Eligible individuals may be&#xD;
      introduced to the study in the orthopedic presurgical clinic or the anesthesia preoperative&#xD;
      clinic by staff. After consent patients will be randomized (break-seal method) to receive&#xD;
      either a mid-thigh or distal thigh block using ropivacaine prior to foot, ankle, or leg&#xD;
      surgery. The following measurements will be obtained to determine the change in sensory&#xD;
      distribution: pinprick test with Neuropen, maximum voluntary isometric contraction before and&#xD;
      after block, postoperative pain scores (24 hrs and at discharge) and postoperative opiate&#xD;
      consumption.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Potential subjects will be identified at the orthopedic presurgical clinic, the anesthesia&#xD;
      preoperative clinic or the Day Surgery Unit. The electronic medical record (Epic) will also&#xD;
      be used for prescreening potential subjects. Recruitment and consenting at will occur at&#xD;
      anesthesia preoperative clinics, Day Surgery Unit. A computer generated randomization list&#xD;
      will be used for randomization list. The research intervention of this study will take place&#xD;
      within the standard clinical context. The patient will receive an ACB regardless of their&#xD;
      participation in this research in accordance with their anesthetic plan and their desires The&#xD;
      experiment will be conducted as follows: A 20-point grid will be drawn on the subject's leg&#xD;
      that will receive medial foot, ankle or leg surgery. Two baseline measurements will be taken&#xD;
      prior to administration of the adductor block: distribution of sensation using pinprick&#xD;
      (Neuropen) method, and muscle contraction strength using a dynamometer. The number of grid&#xD;
      cells with sensation will be counted and recorded. The randomized block will be administered&#xD;
      allowing 20 minutes for anesthetic to take full effect. Post-block measurements include&#xD;
      pinprick in each of the grid cells, where patient will indicate whether sensation is felt or&#xD;
      not. The cells where sensation is perceived will be circled and number of cells will be&#xD;
      recorded. After sensation is recorded, maximum voluntary isometric contraction (MVIC) will&#xD;
      again be measured with the dynamometer to record the maximal contraction strength. Within 24&#xD;
      hours of surgery, the subject will be asked to rate their pain on a scale of 0-10, and will&#xD;
      be recorded again after discharge, in conjunction with opiates required to reduce pain. A&#xD;
      more detailed explanation of experimental steps can be read below.&#xD;
&#xD;
      20-Point Grid: The 20-point grid will be marked starting with anatomical landmarks at the&#xD;
      knee joint: the medial inter-knee joint where the tibia meets the femur, the mid medial&#xD;
      patella, the mid lateral patella, and along the same line at the semitendinosus tendon at 5&#xD;
      cm posterior from that point. Then 5 cm intervals will be plotted progressing cephalad to a&#xD;
      total of 15 cm.&#xD;
&#xD;
      Neuropen test:&#xD;
&#xD;
      Prior to administration of randomized blockade technique a pinprick test will be administered&#xD;
      using a Neuropen on a scale of 0-1, with 1-normal sharp sensation and 0=dull change of&#xD;
      sensation. Mechanical stimulation with pinprick testing is routinely used to test nociception&#xD;
      in the bedside neurologic examination. Sharpness can be considered a surrogate for&#xD;
      nociception because whereas sharpness is not necessarily painful, mechanical thresholds for&#xD;
      sharpness closely parallel those for pain. The subject will be asked to determine whether the&#xD;
      stimulus feels sharp. The number of grid-points with a change in sensation from baseline will&#xD;
      be recorded at baseline and 20 minutes after the block.&#xD;
&#xD;
      MVIC:&#xD;
&#xD;
      Additionally, MVIC will be measured by a handheld dynamometer (Lafayette Instrument Company,&#xD;
      Lafayette Indiana) to determine muscle strength at baseline and after the adductor block. The&#xD;
      patient will be in a seated position with the thigh parallel to the floor and the knee at a&#xD;
      90-degree angle with the feet off the floor. The dynamometer is applied to the leg 5 cm above&#xD;
      the transmalleolar axis and perpendicular to the tibial crest. The patient is instructed to&#xD;
      extend the leg at the knee with sustained maximal force for 5 seconds. This will be repeated&#xD;
      3 times with 30 seconds rest between each movement, and the force will be recorded (Newtons).&#xD;
&#xD;
      Adductor Canal Blockade The adductor canal block will be performed using a linear HFL38xp or&#xD;
      a linear HFL38x ultrasound probe (X-Porte or M-Turbo; SonoSite; Bothell, Washington). The&#xD;
      site that is to receive the ACB will be sterilized with chlorhexidine gluconate 2% and 70%&#xD;
      isopropyl alcohol prep. A skin weal of lidocaine 1% (2-5mL) will be delivered. A Tuohy needle&#xD;
      (17 gauges) will be inserted through the skin wheal under ultrasound guidance towards the&#xD;
      target nerve location. Ropivacaine 0.5% 15ml will be injected for either adductor canal&#xD;
      locations.27 Pain Scores and Opiate Consumption A follow-up visit will be performed in person&#xD;
      for inpatients or via phone for outpatients within 24 hours from discharge to assess for pain&#xD;
      control, and monitoring side effects. It will take 10 minutes. Adverse events will be&#xD;
      monitored during the 24-hour period of the study.&#xD;
&#xD;
      Potential Risks Potential risks include loss of confidentiality or mild discomfort associated&#xD;
      with the pinprick for sensory testing. Risks that are involved with administration of&#xD;
      ropivacaine are primarily damage to surrounding tissues, including nerves, and may cause&#xD;
      bleeding or infection from injection or an unknown allergy to ropivacaine that develops&#xD;
      during the administration of the drug. There are no additional physical or psychological&#xD;
      risks that may result from participation in this research protocol since patients will have&#xD;
      determined that they desire perineural blockade before study inclusion is even proposed.&#xD;
&#xD;
      Subject Safety and Data Monitoring Any serious adverse reaction, including allergy and local&#xD;
      anesthetic systemic toxicity, will result in immediate discontinuation of study related&#xD;
      procedures and treatment as necessary. Serious adverse events will be reported to the&#xD;
      Institutional Review Board. The data already obtained from a participant who has had a&#xD;
      serious adverse event will be analyzed according to intention-to-treat principle.&#xD;
&#xD;
      If non-inferiority between the two neurosensory blockade techniques is significantly detected&#xD;
      at 50% enrollment (or enrollment of 34 patients), the study will be stopped. The study will&#xD;
      also be stopped in the event that there is overwhelming statistical evidence at interim&#xD;
      analysis that the two blocks are different, or in the very small chance that there are&#xD;
      multiple adverse events in the study population.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Unable to complete the sample size needed for 80% power due to changes in surgical approach to&#xD;
    adductor block usage.&#xD;
  </why_stopped>
  <start_date type="Actual">May 26, 2016</start_date>
  <completion_date type="Actual">March 23, 2020</completion_date>
  <primary_completion_date type="Actual">March 23, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Grid Points With Change of Sensation to Pinprick After Blockade</measure>
    <time_frame>20 minutes</time_frame>
    <description>The distribution of cutaneous sensation affected by the different techniques of adductor canal blockade is assessed using a monofilament Neuropen to prick points on a 20 point grid applied to the skin in a standard fashion according to this method: A grid will be marked starting with anatomical landmarks at the knee joint: the medial inter-knee-joint point where the tibia meets the femur, the mid medial patella, the mid lateral patella, and along the same line at the semitendinosus tendon and 5cm posterior from that point. Then 5cm intervals will be plotted progressing cephalad to a total of 15 centimeters. This will yield 20 grid points (5x4 points). Once the grid is made, testing proceeds with a Neuropen on a scale of 0-1, with 1 = normal sharp sensation, 0 = change of sensation. The Neuropen is used for the standardization of force.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">52</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Mid-Thigh Adductor Block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subject will receive a mid-thigh adductor block method using ropivacaine (0.5%, 15 mL).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Distal-Thigh Adductor Block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subject will receive a distal-thigh adductor block method using ropivacaine (0.5%, 15 mL).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <description>Ropivacaine is routinely used to perform localized blockade prior to surgery to improve management of postoperative pain.</description>
    <arm_group_label>Distal-Thigh Adductor Block</arm_group_label>
    <arm_group_label>Mid-Thigh Adductor Block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults aged 18 years or older&#xD;
&#xD;
          -  Individuals undergoing surgery of the medial foot, medial ankle, or medial leg for&#xD;
             which the anesthetic plan includes an adductor canal nerve block&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Any known deficit of the ipsilateral lumbar nerve roots, ipsilateral lumbar plexus,&#xD;
             ipsilateral femoral nerve, obturator nerve or saphenous nerve including diabetic&#xD;
             peripheral neuropathy&#xD;
&#xD;
          2. Any local disorder of the skin or otherwise where blockade is to be performed&#xD;
&#xD;
          3. Body mass index &gt;50&#xD;
&#xD;
          4. American Society of Anesthesiologists (ASA) classification greater than 3&#xD;
&#xD;
          5. Allergy to amide local anesthetic medications&#xD;
&#xD;
          6. Pregnancy&#xD;
&#xD;
          7. Incarceration&#xD;
&#xD;
          8. Inability to understand study procedures including inability to understand the English&#xD;
             language&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anthony Machi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UT Southwestern Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Zale Lipshy University Hospital</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Manickam B, Perlas A, Duggan E, Brull R, Chan VW, Ramlogan R. Feasibility and efficacy of ultrasound-guided block of the saphenous nerve in the adductor canal. Reg Anesth Pain Med. 2009 Nov-Dec;34(6):578-80.</citation>
    <PMID>19916251</PMID>
  </reference>
  <reference>
    <citation>Davis JJ, Bond TS, Swenson JD. Adductor canal block: more than just the saphenous nerve? Reg Anesth Pain Med. 2009 Nov-Dec;34(6):618-9. doi: 10.1097/AAP.0b013e3181bfbf00.</citation>
    <PMID>19901788</PMID>
  </reference>
  <reference>
    <citation>Jaeger P, Grevstad U, Henningsen MH, Gottschau B, Mathiesen O, Dahl JB. Effect of adductor-canal-blockade on established, severe post-operative pain after total knee arthroplasty: a randomised study. Acta Anaesthesiol Scand. 2012 Sep;56(8):1013-9. doi: 10.1111/j.1399-6576.2012.02737.x. Epub 2012 Jul 26.</citation>
    <PMID>22834681</PMID>
  </reference>
  <reference>
    <citation>Tubbs RS, Loukas M, Shoja MM, Apaydin N, Oakes WJ, Salter EG. Anatomy and potential clinical significance of the vastoadductor membrane. Surg Radiol Anat. 2007 Oct;29(7):569-73. Epub 2007 Jul 7.</citation>
    <PMID>17618402</PMID>
  </reference>
  <reference>
    <citation>Jaeger P, Nielsen ZJ, Henningsen MH, Hilsted KL, Mathiesen O, Dahl JB. Adductor canal block versus femoral nerve block and quadriceps strength: a randomized, double-blind, placebo-controlled, crossover study in healthy volunteers. Anesthesiology. 2013 Feb;118(2):409-15. doi: 10.1097/ALN.0b013e318279fa0b.</citation>
    <PMID>23241723</PMID>
  </reference>
  <reference>
    <citation>Machi AT, Sztain JF, Kormylo NJ, Madison SJ, Abramson WB, Monahan AM, Khatibi B, Ball ST, Gonzales FB, Sessler DI, Mascha EJ, You J, Nakanote KA, Ilfeld BM. Discharge Readiness after Tricompartment Knee Arthroplasty: Adductor Canal versus Femoral Continuous Nerve Blocks-A Dual-center, Randomized Trial. Anesthesiology. 2015 Aug;123(2):444-56. doi: 10.1097/ALN.0000000000000741.</citation>
    <PMID>26079800</PMID>
  </reference>
  <reference>
    <citation>Kim DH, Lin Y, Goytizolo EA, Kahn RL, Maalouf DB, Manohar A, Patt ML, Goon AK, Lee YY, Ma Y, Yadeau JT. Adductor canal block versus femoral nerve block for total knee arthroplasty: a prospective, randomized, controlled trial. Anesthesiology. 2014 Mar;120(3):540-50. doi: 10.1097/ALN.0000000000000119.</citation>
    <PMID>24401769</PMID>
  </reference>
  <reference>
    <citation>Bendtsen TF, Moriggl B, Chan V, Pedersen EM, Børglum J. Defining adductor canal block. Reg Anesth Pain Med. 2014 May-Jun;39(3):253-4. doi: 10.1097/AAP.0000000000000052.</citation>
    <PMID>24747312</PMID>
  </reference>
  <reference>
    <citation>Horn JL, Pitsch T, Salinas F, Benninger B. Anatomic basis to the ultrasound-guided approach for saphenous nerve blockade. Reg Anesth Pain Med. 2009 Sep-Oct;34(5):486-9. doi: 10.1097/AAP.0b013e3181ae11af.</citation>
    <PMID>19920424</PMID>
  </reference>
  <reference>
    <citation>Bendtsen TF, Moriggl B, Chan V, Pedersen EM, Børglum J. Redefining the adductor canal block. Reg Anesth Pain Med. 2014 Sep-Oct;39(5):442-3. doi: 10.1097/AAP.0000000000000119.</citation>
    <PMID>25140514</PMID>
  </reference>
  <reference>
    <citation>Jæger P, Lund J, Jenstrup MT, Brøndum V, Dahl JB. Reply to Dr Bendtsen. Reg Anesth Pain Med. 2014 May-Jun;39(3):254-5. doi: 10.1097/AAP.0000000000000069.</citation>
    <PMID>24747313</PMID>
  </reference>
  <reference>
    <citation>Cowlishaw P, Kotze P. Adductor canal block--or subsartorial canal block? Reg Anesth Pain Med. 2015 Mar-Apr;40(2):175-6. doi: 10.1097/AAP.0000000000000205.</citation>
    <PMID>25688724</PMID>
  </reference>
  <reference>
    <citation>Bendtsen TF, Moriggl B, Chan V, Børglum J. Basic Topography of the Saphenous Nerve in the Femoral Triangle and the Adductor Canal. Reg Anesth Pain Med. 2015 Jul-Aug;40(4):391-2. doi: 10.1097/AAP.0000000000000261.</citation>
    <PMID>26079358</PMID>
  </reference>
  <reference>
    <citation>Benzon HT, Sharma S, Calimaran A. Comparison of the different approaches to saphenous nerve block. Anesthesiology. 2005 Mar;102(3):633-8.</citation>
    <PMID>15731603</PMID>
  </reference>
  <reference>
    <citation>López AM, Sala-Blanch X, Magaldi M, Poggio D, Asuncion J, Franco CD. Ultrasound-guided ankle block for forefoot surgery: the contribution of the saphenous nerve. Reg Anesth Pain Med. 2012 Sep-Oct;37(5):554-7. doi: 10.1097/AAP.0b013e3182611483.</citation>
    <PMID>22854395</PMID>
  </reference>
  <reference>
    <citation>Backonja MM, Walk D, Edwards RR, Sehgal N, Moeller-Bertram T, Wasan A, Irving G, Argoff C, Wallace M. Quantitative sensory testing in measurement of neuropathic pain phenomena and other sensory abnormalities. Clin J Pain. 2009 Sep;25(7):641-7. doi: 10.1097/AJP.0b013e3181a68c7e. Review.</citation>
    <PMID>19692807</PMID>
  </reference>
  <reference>
    <citation>Kocarev M, Watkins E, McLure H, Columb M, Lyons G. Sensory testing of spinal anaesthesia for caesarean section: differential block and variability. Int J Obstet Anesth. 2010 Jul;19(3):261-5. doi: 10.1016/j.ijoa.2010.02.002. Epub 2010 Jun 2.</citation>
    <PMID>20627691</PMID>
  </reference>
  <reference>
    <citation>Maffiuletti NA. Assessment of hip and knee muscle function in orthopaedic practice and research. J Bone Joint Surg Am. 2010 Jan;92(1):220-9. doi: 10.2106/JBJS.I.00305.</citation>
    <PMID>20048117</PMID>
  </reference>
  <reference>
    <citation>Lu YM, Lin JH, Hsiao SF, Liu MF, Chen SM, Lue YJ. The relative and absolute reliability of leg muscle strength testing by a handheld dynamometer. J Strength Cond Res. 2011 Apr;25(4):1065-71. doi: 10.1519/JSC.0b013e3181d650a6.</citation>
    <PMID>20838248</PMID>
  </reference>
  <reference>
    <citation>Reinking MF, Bockrath-Pugliese K, Worrell T, Kegerreis RL, Miller-Sayers K, Farr J. Assessment of quadriceps muscle performance by hand-held, isometric, and isokinetic dynamometry in patients with knee dysfunction. J Orthop Sports Phys Ther. 1996 Sep;24(3):154-9.</citation>
    <PMID>8866274</PMID>
  </reference>
  <reference>
    <citation>Walk D, Sehgal N, Moeller-Bertram T, Edwards RR, Wasan A, Wallace M, Irving G, Argoff C, Backonja MM. Quantitative sensory testing and mapping: a review of nonautomated quantitative methods for examination of the patient with neuropathic pain. Clin J Pain. 2009 Sep;25(7):632-40. doi: 10.1097/AJP.0b013e3181a68c64. Review.</citation>
    <PMID>19692806</PMID>
  </reference>
  <reference>
    <citation>Schuirmann DJ. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmacokinet Biopharm. 1987 Dec;15(6):657-80.</citation>
    <PMID>3450848</PMID>
  </reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>May 20, 2016</study_first_submitted>
  <study_first_submitted_qc>May 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 2, 2016</study_first_posted>
  <results_first_submitted>February 25, 2021</results_first_submitted>
  <results_first_submitted_qc>March 24, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">April 21, 2021</results_first_posted>
  <last_update_submitted>March 24, 2021</last_update_submitted>
  <last_update_submitted_qc>March 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Texas Southwestern Medical Center</investigator_affiliation>
    <investigator_full_name>Anthony Machi</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Adductor canal block, nerve block</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 6, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/19/NCT02788019/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Study patients were followed after block procedure for 24 hrs. Adverse events were also monitored within this period.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Mid-Thigh Adductor Block</title>
          <description>Subject will receive a mid-thigh adductor block method using ropivacaine (0.5%, 15 mL).&#xD;
Ropivacaine: Ropivacaine is routinely used to perform localized blockade prior to surgery to improve management of postoperative pain.</description>
        </group>
        <group group_id="P2">
          <title>Distal-Thigh Adductor Block</title>
          <description>Subject will receive a distal-thigh adductor block method using ropivacaine (0.5%, 15 mL).&#xD;
Ropivacaine: Ropivacaine is routinely used to perform localized blockade prior to surgery to improve management of postoperative pain.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
                <participants group_id="P2" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>The study was terminated for failure of enrollment prior to reaching 34 participants in each group.</population>
      <group_list>
        <group group_id="B1">
          <title>Mid-Thigh Adductor Block</title>
          <description>Subject will receive a mid-thigh adductor block method using ropivacaine (0.5%, 15 mL).&#xD;
Ropivacaine: Ropivacaine is routinely used to perform localized blockade prior to surgery to improve management of postoperative pain.</description>
        </group>
        <group group_id="B2">
          <title>Distal-Thigh Adductor Block</title>
          <description>Subject will receive a distal-thigh adductor block method using ropivacaine (0.5%, 15 mL).&#xD;
Ropivacaine: Ropivacaine is routinely used to perform localized blockade prior to surgery to improve management of postoperative pain.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="27"/>
            <count group_id="B2" value="25"/>
            <count group_id="B3" value="52"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="27"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="52"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="33"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="27"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="52"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56.62" spread="15.02"/>
                    <measurement group_id="B2" value="57.84" spread="12.37"/>
                    <measurement group_id="B3" value="57.21" spread="13.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="27"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="52"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="32"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="27"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="52"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI</title>
          <units>kg/m^2</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="27"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="52"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28.5" lower_limit="25.8" upper_limit="35.0"/>
                    <measurement group_id="B2" value="30.9" lower_limit="24.4" upper_limit="34.7"/>
                    <measurement group_id="B3" value="29.8" lower_limit="24.95" upper_limit="34.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Grid Points With Change of Sensation to Pinprick After Blockade</title>
        <description>The distribution of cutaneous sensation affected by the different techniques of adductor canal blockade is assessed using a monofilament Neuropen to prick points on a 20 point grid applied to the skin in a standard fashion according to this method: A grid will be marked starting with anatomical landmarks at the knee joint: the medial inter-knee-joint point where the tibia meets the femur, the mid medial patella, the mid lateral patella, and along the same line at the semitendinosus tendon and 5cm posterior from that point. Then 5cm intervals will be plotted progressing cephalad to a total of 15 centimeters. This will yield 20 grid points (5x4 points). Once the grid is made, testing proceeds with a Neuropen on a scale of 0-1, with 1 = normal sharp sensation, 0 = change of sensation. The Neuropen is used for the standardization of force.</description>
        <time_frame>20 minutes</time_frame>
        <population>Only patients who were enrolled and had data for both pre and post blockade were considered for this analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Mid-Thigh Adductor Block</title>
            <description>Subject will receive a mid-thigh adductor block method using ropivacaine (0.5%, 15 mL).&#xD;
Ropivacaine: Ropivacaine is routinely used to perform localized blockade prior to surgery to improve management of postoperative pain.</description>
          </group>
          <group group_id="O2">
            <title>Distal-Thigh Adductor Block</title>
            <description>Subject will receive a distal-thigh adductor block method using ropivacaine (0.5%, 15 mL).&#xD;
Ropivacaine: Ropivacaine is routinely used to perform localized blockade prior to surgery to improve management of postoperative pain.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Grid Points With Change of Sensation to Pinprick After Blockade</title>
          <description>The distribution of cutaneous sensation affected by the different techniques of adductor canal blockade is assessed using a monofilament Neuropen to prick points on a 20 point grid applied to the skin in a standard fashion according to this method: A grid will be marked starting with anatomical landmarks at the knee joint: the medial inter-knee-joint point where the tibia meets the femur, the mid medial patella, the mid lateral patella, and along the same line at the semitendinosus tendon and 5cm posterior from that point. Then 5cm intervals will be plotted progressing cephalad to a total of 15 centimeters. This will yield 20 grid points (5x4 points). Once the grid is made, testing proceeds with a Neuropen on a scale of 0-1, with 1 = normal sharp sensation, 0 = change of sensation. The Neuropen is used for the standardization of force.</description>
          <population>Only patients who were enrolled and had data for both pre and post blockade were considered for this analysis.</population>
          <units>points of cutaneous sensation</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.81" spread="0.55"/>
                    <measurement group_id="O2" value="20" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse Event data was collected from the time point of receiving an adductor block up to 24 hrs post block.</time_frame>
      <desc>We used an electronic version of the National Center for Complementary and Integrative Health (United States National Institutes of Health) adverse collection form.</desc>
      <group_list>
        <group group_id="E1">
          <title>Mid-Thigh Adductor Block</title>
          <description>Subject will receive a mid-thigh adductor block method using ropivacaine (0.5%, 15 mL).&#xD;
Ropivacaine: Ropivacaine is routinely used to perform localized blockade prior to surgery to improve management of postoperative pain.</description>
        </group>
        <group group_id="E2">
          <title>Distal-Thigh Adductor Block</title>
          <description>Subject will receive a distal-thigh adductor block method using ropivacaine (0.5%, 15 mL).&#xD;
Ropivacaine: Ropivacaine is routinely used to perform localized blockade prior to surgery to improve management of postoperative pain.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <default_vocab>See site above</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Skin lesion</sub_title>
                <description>Patient developed herpes zoster lesions on flank of the side he received his block in.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Anthony Machi, MD, Assistant Professor</name_or_title>
      <organization>UT Southwestern Medical Center</organization>
      <phone>214-648-6400</phone>
      <email>Anthony.Machi@UTSouthwestern.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

